Hyperlipidemias  >>  Rovelito (atorvastatin/irbesartan)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rovelito (atorvastatin/irbesartan) / Hanmi, Sanofi
NCT01442987: Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Completed
3
230
RoW
Irbesartan/Atorvastatin A, HCP0912 A, Irbesartan, Atorvastatin A, Placebo, Irbesartan/Atorvastatin B, HCP0912 B, Atorvastatin B
Hanmi Pharmaceutical Company Limited
Hypertension, Hyperlipidemia
04/13
05/13

Download Options